Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baminercept in Secondary Progressive Multiple Sclerosis
NCT01181089Phase 2Withdrawn
- Sponsor
- Biogen
- Start
- Sep 2010
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 2 trial of baminercept in secondary-progressive multiple sclerosis (SPMS), sponsored by Biogen. Planned start Sep 2010; status: withdrawn.
02
Drugs
baminercept
03
Conditions
secondary-progressive multiple sclerosis (SPMS)
Beyond the preview
Go deeper on NCT01181089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01181089.